|
|||||
|
|
||||||
Journal of Clinical Oncology, Vol 26, No 7 (March 1), 2008: pp. 1175-1177 © 2008 American Society of Clinical Oncology. DOI: 10.1200/JCO.2007.12.8751
Concealment of Information in Clinical Practice: Is Lying Less Stressful Than Telling the Truth?
From the Lab of Hygiene; Lab of Physiology, Medical School, Aristotle University, Thessaloniki, Greece Corresponding author: E. Panagopoulou, Lab of Hygiene, 54124, Medical School, Aristotle University, Thessaloniki, Greece; e-mail: efharis{at}the.forthnet.gr INTRODUCTION Despite international trends toward patient autonomy and shared decision making, concealment of diagnostic or prognostic information from cancer patients is still common in clinical practice.1,2 Studies conducted in different countries show that up to 60% of cancer patients are not aware of their diagnoses despite developments in cancer treatments and moves toward patient empowerment.3-5 Even in Western medical settings, oncologists are often hesitant to disclose the diagnosis directly, and often censor prognostic information favoring either nondisclosure or a conscious overestimate.6 In a study conducted in five United States hospices, physicians reported that they would provide frank disclosure of survival estimates only in 37% of cases.7 Similarly, a survey of 126 Australian cancer patients showed that 87% of physicians gave the prognosis to the family first.8 When asked about their reasons for nondisclosure, physicians report that they do it primarily out of respect for the wishes of the family, or concern for the patient's well-being.9,10 However, do the aforementioned reasons adequately explain the concealment practices observed? Fallowfield and Jenkins11 have suggested that physicians may conceal unpleasant information in an attempt to protect their own emotional well-being as much as the patients'. To date, no study has examined the extent to which physicians might benefit from concealing unpleasant information. In other words, is concealment of bad news less stressful than disclosure? Based on studies showing the beneficial role of perceived control, we hypothesized that concealment of cancer diagnosis would be less stressful than disclosure. To test whether our hypothesis had any empirical validity, we conducted a small experiment examining the emotional and physiological impact of disclosing versus concealing cancer diagnosis. EXPERIMENT To control for the confounding effects of clinical experience and sex, only male medical students attending preclinical education were included in the experiment. Students were recruited using an advertisement via the medical student newspaper. Students were excluded if they had a history of malignant disease in their immediate family. Of the 94 students who responded to the advertisement, 67 met all inclusion criteria and were invited to participate. The average age was 24 years (standard deviation = 2). Participants were randomly divided into three groups; concealment, disclosure, and control. Participants in all groups were informed that they would have a 5-minute consultation with a 26-year-old woman with a nonoperable brain tumor and an expected survival time of 2 years. They were also given information about prognosis, treatment, and side effects. "In the next 5 minutes you will meet Mary, who is coming to get the results of her tests. Mary has originally come to visit you complaining of recurring headaches, which she had attributed to stress. She is 26 years old, recently married, and currently trying for a baby. Her test results have shown an inoperable brain tumor. The suggested treatment is systemic chemotherapy for four to five courses at 4-week intervals. Her expected survival time after treatment is 2 years". Following that, participants in the disclosure group (n = 22) were instructed to disclose complete information about diagnosis, prognosis, and treatment. In the concealment group (n = 22), participants were instructed to conceal the true diagnosis, but still refer the patient for treatment. Participants in a control group (n = 23) were simply asked to conduct a standardized interview about dietary habits. In all conditions, the same "medical actress" was used. She was given a list of specific questions, and was trained to respond in the same "neutral" way to all conditions, avoiding the display of overt emotional behavior. Consultations were audio recorded. Psychological stress, and positive and negative mood, were assessed at baseline, after reading the instructions (anticipatory stress), and after the end of the consultation. Perceived threat and perceived control were assessed after reading the instructions (anticipatory appraisals) and after the end of the consultation. Heart rate was assessed during the consultation in real-time, with recordings acquired from a digital pulse oxymeter measuring heart beats per minute. Psychological stress was assessed using the State Trait Anxiety Inventory.13 In addition, positive and negative moods were assessed with the Positive and Negative Affect Scale.14 Perceived threat control over the situation were assessed using a six-item Visual Analog Scale, which has been employed in previous studies assessing appraisals of stressful situations.15 Data collection took place in April 2006, on weekdays between 17:00 and 20:00. After signing an informed consent, participants completed the baseline assessments of stress and mood (T1). They were then randomly assigned to one of the study groups. After reading the instructions of their group, they were asked to wait in a different room for 30 minutes. During the anticipation period, the use of mobile phones, electronic music devices, or any reading material was not permitted. After the end of the anticipation period (T2), they completed the measures of stress and mood, as well as the measures of perceived threat and control. They were then shown to the consultation room. Psychological stress, mood, and perceived threat and control were also assessed at the end of the consultation (T3). After the third assessment, a trained clinical psychologist debriefed participants. Changes in psychological stress and mood were examined using analysis of variance for repeated measurements. Differences in perceived threat and control were assessed using univariate analysis of variance. The average heart rate during the initial 2 minutes of the consultation was compared with the average heart rate during the last 2 minutes of the consultation (total duration of consultation was 5 minutes) using a paired samples t test. Compared with the control group, there was a significant increase in anxiety in both the concealment and the disclosure group from T1 to T2 (Fig 1). However, in the concealment group, anxiety significantly decreased from T2 to T3 and returned to baseline levels, while in the disclosure group, anxiety levels remained high in T3 (P = .018).
Similarly, compared with the control group, a significant increase was observed in negative mood in both experimental groups from T1 to T2 (Fig 2). However, in the concealment group, negative mood significantly decreased from T2 to T3 and returned to baseline levels, while in the disclosure group, negative mood remained high in T3 (P = .019).
The opposite pattern emerged for positive mood (Fig 3). Compared with the control group, positive mood significantly decreased in both experimental groups from T1 to T2. However, in the concealment group, positive mood significantly increased from T2 to T3 and returned to baseline levels, while in the disclosure group, positive mood remained decreased in T3 (P = .002).
The disclosure and the concealment groups perceived the consultation as significantly more threatening than the control group. This was true for anticipatory (P = .014) and postconsultation assessments (P = .009). However, the concealment group experienced higher control before (P = .002) and after the consultation (P = .005), compared with both the disclosure and the control groups. Finally, in the disclosure and control groups, no difference was observed between heart rate at the beginning and the end of the consultation. However, in the concealment group, heart rate significantly decreased from the beginning to the end of the consultation (P = .011). So, the group who concealed the information felt both psychologically and physiologically better, and more in control. DISCUSSION
Is Concealing Bad News Less Stressful Than Disclosing? The fact that no changes were observed in the control group, in any of the outcome measures, suggests that knowledge alone does not initiate stress. The stress reaction appears to be initiated by the need to interact with patients about their conditions. Although participants in the control group were aware of the patient's medical condition, they did not have to deal with it since they were simply instructed to conduct a standardized interview about dietary habits. Previous studies have suggested that the stress of delivering bad news begins from the moment the physician becomes aware of the need to provide some diagnostic information, and lasts several days later.16 The results support the notion that anticipating interaction with terminally ill patients about their conditions is stressful, and that concealment helps to reduce the stress experienced . This finding highlights the fact that, in addition to patients preferences and family values, physicians coping skills and emotional reactions can influence truth-telling in clinical practice. Previous studies have shown that the more grave and distressful the information is, the less likely oncologists are to disclose it.17,18
Why Is Concealing Bad News Less Stressful Than Disclosing? CONCLUSION Concealing diagnostic information from terminally ill patients seems to be less stressful than revealing the truth about the diagnosis. The message of this current project is not that disclosure is harmful, but rather that concealment is a response to a perceived stressor. When faced with a fight-or-flight situation, physicians may be likely to choose the option that will most effectively reduce their levels of stress. If the primary reason for physicians to conceal is the short-term benefit of increased control and avoidance of emotional reactions, then this emphasizes that stress management should be an integral part of clinical skills training. Better insight into the motivations for the existing differences in truth-telling practices is needed. AUTHORS DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST The author(s) indicated no potential conflicts of interest.
NOTES The first and second author have conducted the same amount of work and share first authorship. Authors disclosures of potential conflicts of interest and author contributions are found at the end of this article. REFERENCES 1. Girgis A, Sanson-Fischer RW: Breaking bad news: Consensus guidelines for medical practicioners. Behav Med 24:53-59, 1995 2. SCOPE. Right from the start template: Good practice in sharing the news. London, UK, Department of Health 8, 2003 3. Jiang Y, Li JY, Liu C, et al: Different attitudes of oncology clinicians toward truth telling of different stages of cancer. Support Care Cancer 14:1119-1125, 2006[CrossRef][Medline] 4. Costantini M, Morasso G, Montella M, et al: Diagnosis and prognosis disclosure among cancer patients. Results from an Italian mortality follow-back survey. Ann Oncol 17:853-859, 2006 5. Miyashita M, Hashimoto S, Kawa M, et al: Attitudes towards disease and prognosis disclosure and decision making for terminally ill patients in Japan, based on a nationwide random sampling survey of the general population and medical practitioners. Palliat Support Care 4:389-398, 2006[CrossRef][Medline] 6. Mitchell A: Reluctance to disclose difficult diagnoses: A narrative review comparing communication by psychiatrists and oncologists. Support Care Cancer 15:819-828, 2007[CrossRef][Medline] 7. Lamont EB, Christakis NA: Prognostic disclosure to patients with cancer near the end of life. Ann Intern Med 134:1096-1105, 2001 8. Hagerty RG, Butow PN, Ellis PM, et al: Communicating with realism and hope. J Clin Oncol 23:1278-1288, 2005 9. Helft PR: Necessary collusion: Prognostic communication with advanced cancer patients. J Clin Oncol 23:3146-3150, 2005 10. Elwyn TS, Fetters MD, Sasaki H, et al: Responsibility and cancer disclosure in Japan. Soc Sci Med 54:281-293, 2002[CrossRef][Medline] 11. Fallowfield L, Jenkins V: Communicating bad, sad, and difficult news in medicine. Lancet 363:312-319, 2004[CrossRef][Medline] 12. Spielberger CD, Gorsuch RL, Lushene RE: Manual for the State-Trait Anxiety Inventory. Palo Alto, CA, Consulting Psychologists Press, 1970 13. Watson D, Clark LA, Tellegen A: Development and validation of brief measures of positive and negative affect: The PANAS scales. J Pers Soc Psychol 54:1063-1070, 1988[CrossRef][Medline] 14. Gaab J, Rohleder N, Nater UM: Psychological determinants of the cortisol stress response: The role of anticipatory cognitive appraisal. Psychoneuroendocrinology 1:599-610, 2005 15. Ptacek JT, Fries EA, Eberhardt TL, et al: Breaking bad news to patients: Physicians perceptions of the process. Support Care Cancer 7:113-120, 1999[CrossRef][Medline] 16. Baile WF, Lenzi R, Parker PA, et al: Oncologists attitudes toward and practices in giving bad news: An exploratory study. J Clin Oncol 20:2189-2196, 2002 17. Ptacek JT, Eberhardt TL: Breaking bad news: A review of the literature. JAMA 1276:496-502, 1996 18. Friedrichsen M, Milberg A: Concerns about losing control when breaking bad news to terminally ill patients with cancer: Physicians perspective. J Palliat Med 9:673-682, 2006[CrossRef][Medline] Submitted May 31, 2007; accepted June 21, 2007.
This article has been cited by other articles:
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2008 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|